D-0108-2018 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

FDA drug recall D-0108-2018 was initiated by Teva Pharmaceuticals USA on Nov 28, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities. The recall status is terminated (terminated Jul 3, 2018). Affected quantity: 42,384 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 20, 2017
Initiation Date
Nov 28, 2017
Termination Date
Jul 3, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
42,384 bottles

Product description

Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only, Manufactured In Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454; NDC 0093-4125-73.

Reason for recall

Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.

Distribution pattern

Nationwide in the USA and Puerto Rico.

Code information

Lot # 35433115A, Exp 01/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0108-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0108-2018. Report a data issue: hello@regdatalab.com.